Find Jobs
Find Jobs Near You – Available Work in Your Location
Skip to job details
NT
Nurix Therapeutics
VP/SVP, Global Development Leader
Career Insights for Vice President (General)
See where this job fits in the broader career landscape. Knowing your career path helps you see what's possible from here.
Scorecard
Based on California data
Review key factors to help you decide if this role fits your goals. How is this calculated?
What they do
A Vice President is a high-level manager at a company of organization. Often reports to the President of the company or organization, and sometimes oversees the entirety of one division, department, or sector.
$215,352 / year median in California
-2% projected decline
Job Description
Job Details Vice President / Senior Vice President, Global Development Leader (Bexobrutideg) Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease. We are seeking a brilliant, organized and highly motivated leader who will provide strategic and tactical medical leadership and will deliver key clinical and scientific leadership to clinical development programs while ensuring the highest standard for safety and compliance with regulatory requirements and standard procedures. The ideal candidate should have experience working in a fast-paced dynamic environment. The successful candidate will report to the Chief Medical Officer. The responsibilities of this leader are listed below. Lead one or more Program teams comprised of functional representatives from Clinical Development (Clinical Operations, Medical Monitoring, Clinical Science), Research and Translational Medicine, Regulatory, Technical Operations, Quality, and Commercial from phase 1 through phase 3 and through approval and launch; serve as the single point of accountability for the BTK Program Global Development Team (GDT), and to create and drive key program decisions through appropriate governance forums, where appropriate As a member of the Clinical Executive Management Team, partner with stakeholders to set clear direction and execute against goals for a portfolio of clinical stage therapies, ensuring the development and execution of program strategy is in line with corporate strategy and goals Drive the development and communication of program plans and development plan in partnership with the asset teams and program management Facilitate cross-functional communication; drive strategic and operational alignment with the Program team, functional leads, and Executive Management Team Identify challenges and risks and prepare the team with mitigations to navigate through technical and program challenges as they arise Develop or participate in the refinement/update of the Clinical Development Plan (CDP); act as or oversee the clinical leads for protocols and supportive activities to meet the CDP objectives Provide medical oversight for ongoing clinical trials including regular review of clinical data to improve understanding of the molecule profile, including but not limited to safety and activity Provide clinical oversight for Company operational staff and contract research organizations (CROs) in all areas related to the execution of therapeutic programs Provide and or oversee training and ongoing input to all members of the clinical team on medical and scientific issues related to the appropriate therapeutic field Provide medical support for all relevant regulatory discussions and activities, such as IND's and NDA/MAAs Interact with principal investigators and opinion leaders to facilitate clinical trials research Refine and or establish processes and methods for design and implementation of applicable clinical protocols, data collection systems and final reports Data presentation to executive leaders, internal and external medical colleagues in one on one or large group settings (50+). Required Qualifications MD, board certified preferably in hematology/oncology Requires at least 10 years' clinical trial experience in the setting of pharmaceutical industry with demonstrated experience and involvement in clinical trial design or execution. In particular, Ph3 clinical trial planning and execution. Relevant clinical research experience in academic settings will be reviewed in light of clinical development experience Excellent communicator with proven leadership skills and the ability to interact in a cross functional environment Comfortable in a fast-paced small company environment with minimal direction and able to adjust workload based upon changing priorities Proven leadership experience leading high performing teams and individuals Hands on leadership approach will be best suited for this critical role Experience working in a highly productive and high achieving collaboration Fit with Nurix Culture and Values Strong team orientation; highly collaborative Solutions and results-oriented focus Hands-on approach; resourceful and open to diverse points of view Company Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurix's extensive expertise in E3 ligases together with its proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to identify and advance novel drug candidates targeting E3 ligases, a broad class of enzymes that can modulate proteins within the cell. Nurix's drug discovery approach is to either harness or inhibit the natural function of E3 ligases within the ubiquitin proteasome system to selectively decrease or increase cellular protein levels. Nurix's wholly owned pipeline comprises targeted protein degraders of Bruton's tyrosine kinase, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, an E3 ligase that regulates T cell activation. Nurix is headquartered in San Francisco, California.